New active ingredients for drugs to treat infections, cancer or other serious diseases are often based on substances originally discovered in microorganisms, plants or other living organisms.
NVIDIA Corporation announced collaborations with leading global healthcare and research organizations to advance protein design ? including through a newly released open model, RFD4-Proteina ?
ABU DHABI, 21st October, 2026 (WAM) -- The Department of Health – Abu Dhabi (DoH), the regulator of the health sector in Abu Dhabi, and Isomorphic Labs, the leading AI-first drug design and ...
The American Museum of Science and Energy offers free admission this Saturday for Nuclear Energy Discovery Day.
PerturbAI, an AI-native biotechnology company, today announced results from its year-long collaboration with OpenAI to advance biomedical research and drug discovery. Working with Scripps Research, ...
A Florida State University computer scientist won a $100,000 grand prize from cybersecurity company ReliaQuest after ...
Researchers don't need another tool that gives them more papers to read,” says QED Science CEO Niv Mastboim, launching ...
Brooks Consulting's Chuck Brooks, a GovCon Expert, examines the White House’s 2026 National Security Science & Technology Strategy.
Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the ...
The new lab will increase the pace of biological scientific research by orders of magnitude, said speakers at its ...
A new National Academies report recommends exploring four lunar sites to allow astronauts to pursue important ...